News

Fresenius Kabi to announce the commercial launch of Tyenne®*, the first and only approved tocilizumab biosimilar in Canada
Fresenius Kabi's tocilizumab biosimilar Tyenne® is the first and only tocilizumab biosimilar to be launched in Canada and is ...